News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biolipox AB Raises $41 Million To Advance Preclinical Inflammation Programs



10/19/2005 5:12:12 PM

Biolipox AB, a firm developing anti-inflammatory drugs based on its knowledge of arachidonic acid metabolic pathways, disclosed Monday that it raised $41 million in a Series C round led by Scandinavian Life Science Venture.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES